Needle Technology for Insulin Administration: A Century of Innovation. (March 2023)

• Record Type: Journal Article
• Authors: Heinemann, Lutz; Nguyen, Trung; Bailey, Timothy S.; Hassoun, Ahmed; Kulzer, Bernd; Oliveria, Teresa; Reznik, Yves; de Valk, Harold W.; Mader, Julia K.
• Is Part Of: Journal of diabetes science and technology. Volume 17:Number 2(2023)
• Page Start: 449
• Page End: 457
• Publication Date: 2023-03
• Subjects: insulin administration -- insulin therapy -- needle length -- insulin pen -- subcutaneous -- syringe; Diabetes -- Periodicals; Medical technology -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462005
• DOI: 10.1177/19322968211059564
• Languages: English
• ISSNs: 1932-2968

Abstract

Innovations in syringe and pen needle (PN) technology over the last 100 years have led to important advances in insulin delivery for people with diabetes, paralleling the strides made in developing recombinant DNA human insulin and insulin analogs with varying onset and duration of action. In this review, the history of advances in insulin delivery is described, focusing on progress in syringe, needle, and PN technologies. The early glass and metal syringes that required sterilization by boiling have been replaced by disposable, single-use syringes or pens with clear labeling for precise insulin dosing. The early needles ranging in length from 19 to 26 mm that required manual sharpening against a whetstone have been replaced by syringe needles of 6 mm and PNs of 4 mm in length as slender as 34 gauge. Imaging studies using ultrasound and computed tomography measured the thickness of skin and subcutaneous tissue layers to show feasibility of targeted insulin administration with shorter needles. These developments, coupled with innovations in needle/PN wall and tip structure, have led to improved injection experience for people with diabetes. It is also important to acknowledge the role of injection technique education, together with these advances in injection technology, for improving clinical outcomes and patient satisfaction. With continued projected growth of diabetes prevalence, particularly in developing countries where expensive and complex insulin delivery systems may not be practical, insulin syringes and pens will continue to serve as reliable and cost-effective means of insulin delivery for people with diabetes.